A bottle of Johnson’s child powder.
| Photo Credit: AP
Johnson & Johnson is earmarking practically $9 billion to cowl allegations that its child powder containing talc brought on most cancers, greater than quadrupling the quantity that the firm had beforehand put aside to pay for its potential legal responsibility.
Under a proposal introduced on April 4, a J&J subsidiary will re-file for Chapter 11 chapter safety and search court docket approval for a plan that might end in one of many largest product-liability settlements in U.S. historical past.
The $8.9 billion that J&J would switch to the subsidiary, LTL Management, can be payable over the subsequent 25 years. The quantity is up from the $2 billion that the New Brunswick, New Jersey, firm put aside in October 2021.
The revised quantity is being backed by greater than 60,000 events which have filed lawsuits alleging hurt from J&J talcum powder, in accordance to the corporate.
J&J is not admitting any wrongdoing as a part of the proposed settlement, a degree that the corporate government emphasised in a Tuesday assertion that maintained the claims “are specious and lack scientific merit.”
But preventing the lawsuits in court docket would take many years and be costly, stated Erik Haas, J&J’s worldwide vp of litigation.
The lawsuits filed towards J&J had alleged its talcum powder brought on customers to develop ovarian most cancers, by use for female hygiene, or mesothelioma, a most cancers that strikes the lungs and different organs.
The claims contributed to drop in J&J’s gross sales of child powder, prompting the corporate to cease promoting its talc-based merchandise in 2020. Last 12 months, J&J introduced plans to stop gross sales of the product worldwide.
J&J’s inventory rose 3% in after-hours buying and selling Tuesday after the corporate’s announcement.
